Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of CYP2C9-Interacting Drugs on Warfarin Pharmacogenomics.

Autor: Agrawal S; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Heiss MS; Graduate Program in Genetic Counseling, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Fenter RB; Graduate Program in Genetic Counseling, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Abramova TV; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Perera MA; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Pacheco JA; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Smith ME; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Rasmussen-Torvik LJ; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., George AL Jr; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2020 Sep; Vol. 13 (5), pp. 941-949. Date of Electronic Publication: 2020 Apr 09.